Find / Register for a Course



2017 Emerging Therapies for PBC, NASH, ESLD and HCC


Cities and Dates:
Chicago, IL
Saturday, February 25
Louisville, KY
Saturday, March 4
San Francisco, CA
Saturday, March 11
Houston, TX
Saturday, March 25
Los Angeles, CA
Saturday, April 8
San Diego, CA
Saturday, May 13
Miami, FL
Saturday, May 20
Seattle, WA
Saturday, June 10
New York, NY
Saturday, June 17
Washington, D.C.
Saturday, June 24

Venues:

ATTENTION - ALL programs EXCEPT San Diego
will run from 8:00am – 3:00pm
San Diego on May 13 will run from 11:00am – 6:00pm

Chicago, IL
Saturday, February 25
Courtyard by Marriott Downtown
161 East Ontario Street
Chicago, Illinois 60611
312-573-0800

Louisville, KY
Saturday, March 4
University of Louisville Center
for Translational Research
505 South Hancock Street
Louisville, Kentucky 40202

San Francisco, CA
Saturday, March 11
DoubleTree CFO North
5000 Sierra Point Parkway
Brisbane, California 94005
415-467-4400

Houston, TX
Saturday, March 25
Hilton Houston Plaza / Medical Center
6633 Travis Street
Houston, Texas 77030
713-313-4000

Los Angeles, CA
Saturday, April 8
Embassy Suites - LAX North
9801 Airport Boulevard
Los Angeles, California 90045
310-633-8399

San Diego, CA
Saturday, May 13
Marriott Del Mar
119166 El Camino Real
San Diego, California 92130
858-523-1700

Miami, FL
Saturday, May 20
Sheraton Miami International
3900 North West 21st Street
Miami, Florida 33142
305-871-3800

Seattle, WA
Saturday, June 10
Hyatt at Olive 8
1635 8th Avenue
Seattle, Washington 98101
206-695-1234

New York, NY
Saturday, June 17
DoubleTree Suites - Times Square
1568 Broadway
New York, New York
212-719-1600

Washington, D.C.
Saturday, June 24
Hilton Alexandria – Old Town
1767 King Street
Alexandria, Virginia, 22314
703-837-0440

Seminar Overview

This seminar series will provide updates on the latest clinical research but with a strong focus on patient care. Teams of local hepatology experts (physicians and mid-level providers) will provide an interdisciplinary approach to diagnosis and treatment in a classroom setting that stresses strong interaction between participants and faculty. Further, the interdisciplinary faculty promotes how optimal patient outcomes can be achieved through a team approach.

To lower the barriers to participation and increase access, the program will be offered on Saturdays at ten cities throughout the country beginning in February 2017. See the calendar of programs

The seminar will concentrate on key diseases of the liver and address the latest diagnosis, treatment and care management approaches for each.

Primary Biliary Cholangitis Cirrhosis (PBC) is an old disease but one that is experiencing some major changes. First, the name has replaced the former title of Primary Biliary Cirrhosis and a new treatment, Obetacholic Acid (OCA), the first new drug for the disease in 20 years. It is widely expected that this therapy drug will be a breakthrough for patients who have had an incomplete response to Ursodiol (URSO).
Non-Alcoholic Steatohepatitis (NASH) is an epidemic in the US and is expected to be the major cause of cirrhosis in the coming decades as chronic Hepatitis C wanes. There are many unmet needs associated with this disease including simple biomarkers to help diagnose it and follow experimental therapies. Clinical experts will provide a thorough review of non-invasive diagnostic testing for the disease and discuss several interesting and exciting drugs that are being developed for NASH
End Stage Liver Disease (ESLD) is expected to grow in prevalence through 2020, largely due to the burden of chronic viral hepatitis that exists in our population. As these patients age, a larger number will develop decompensation events such as bleeding from esophageal varices, hepatic encephalopathy, hyponatremia and renal failure.
Hepatocellular Carcinoma (HCC) is the most common form of liver cancer and occurs predominantly in patients with underlying chronic liver disease and cirrhosis. HCC is now the third leading cause of cancer deaths worldwide, with over 500,000 people affected. New research is yielding some promising therapies.

Seminar Highlights

  • Updates on the latest clinical guidelines with strong patient-focused educational sessions using evidence-based studies from AASLD, EASL and recent clinical trial outcomes.
  • Teams of local experts, comprised of physicians and mid-level providers, providing an interdisciplinary team approach to treatment.
  • Small classroom learning environment to promote interaction with faculty and between participants.

  • Target Audience

    This program is especially suited for
    • Hepatologists
    • Gastroenterologists
    • Oncologists
    • Infectious Disease Specialists
    • Internists
    • Family Physicians
    • As well as related Fellows, Residents, Nurse Practitioners, Physician Assistants and Nurses.




    Course Registration »

    For more information:

    University of Louisville Office of CME and Professional Development
    501 E. Broadway Su 370
    Louisville, KY 40202

    Phone: (502) 852-5329
    Email: cmepd@louisville.edu